Choksi Asia (BOM:530427) Other Stockholders Equity: ₹0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530427 Choksi Asia Ltd BOM:530427
52 GF Score
Price ₹250.00
! 8 Warning Signs
View Full Analysis

What is Choksi Asia Other Stockholders Equity?

Choksi Asia BOM:530427 +2.88% 52 Other Stockholders Equity is ₹0.0 Mil as of Jun. 2026. GuruFocus rates BOM:530427 with a GF Score™ of 52/100. The stock has 8 warning signs investors should review.

Choksi Asia's Other Stockholders Equity for the quarter that ended in Jun. 2026 was ₹0.0 Mil.

Choksi Asia's quarterly Other Stockholders Equity increased from Dec. 2025 (₹0.0 Mil) to Mar. 2026 (₹310.2 Mil) but then declined from Mar. 2026 (₹310.2 Mil) to Jun. 2026 (₹0.0 Mil).

Choksi Asia's annual Other Stockholders Equity declined from Mar. 2024 (₹5.7 Mil) to Mar. 2025 (₹5.7 Mil) but then increased from Mar. 2025 (₹5.7 Mil) to Mar. 2026 (₹310.2 Mil).

Choksi Asia Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Choksi Asia's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Choksi Asia Other Stockholders Equity Chart

Choksi Asia Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.68 5.68 5.68 5.68 310.17

Choksi Asia Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 280.86 0.00 310.17 0.00
BOM:530427
52GF Score
Choksi Asia Ltd BOM:530427
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Choksi Asia Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ₹0.0 Mil mean?
Choksi Asia (BOM:530427) has a Other Stockholders Equity of ₹0.0 Mil as of Jun. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Choksi Asia and its competitors.
Is Choksi Asia's Other Stockholders Equity too high?
Choksi Asia's current Other Stockholders Equity is ₹0.0 Mil. Overall, Choksi Asia has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Choksi Asia's Other Stockholders Equity compare to ABT and SYK?
Choksi Asia's Other Stockholders Equity of ₹0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Choksi Asia and its competitors. Choksi Asia's current Other Stockholders Equity is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Choksi Asia stock overvalued right now?
Choksi Asia (BOM:530427) has a current Other Stockholders Equity of ₹0.0 Mil. The current Other Stockholders Equity is ₹0.0 Mil. Choksi Asia's overall GF Score™ is 52/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Choksi Asia (BOM:530427), the current Other Stockholders Equity is ₹0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Choksi Asia Business Description

Address Nehru Road, No. 163/164, Choksi Bhuvan, Ville Parle (East), Mumbai, MH, IND, 400057
Choksi Asia Ltd formerly Choksi Imaging Ltd is an India-based company engaged in the manufacturing of photosensitized materials, medical X-rays, and other healthcare products. The company sells and derives revenue from products like X-ray films, ultrasound, computed radiography systems, specialty X-ray films, etc. In addition, the company also offers maintenance services for X-ray processors, equipment, and computer radiography systems. The firm provides various photographic, and ultrasonic sound services in association with Protec, Medtron, and others.
52GF Score

Get the complete analysis for BOM:530427

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹250.00
Price